基因敲除
血管平滑肌
基因沉默
下调和上调
免疫印迹
小干扰RNA
体内
细胞生物学
长非编码RNA
RNA干扰
体外
小RNA
生物
分子生物学
转染
化学
癌症研究
核糖核酸
基因
生物化学
内分泌学
遗传学
平滑肌
作者
R. Zhang,Fan Bu,Yubing Wang,Mei Huang,Xiao-Min Lin,Chang-Meng Wu,Juanjiang Chen,Yiyi Huang,Haifang Wang,Shu Ye,Xiumei Hu,Qian Wang,Lei Zheng
出处
期刊:Atherosclerosis
[Elsevier]
日期:2023-08-01
卷期号:379: 117183-117183
被引量:1
标识
DOI:10.1016/j.atherosclerosis.2023.06.974
摘要
Background and aims The aberrant proliferation and migration of vascular smooth muscle cells (VSMCs) plays the essential role in the pathogenesis of atherosclerosis (AS). Long noncoding RNAs (lncRNAs) have been reported as important regulators in a number of diseases. However, the very little is known regarding the functional role of lncRNAs in governing proliferation and migration of VSMCs and AS development. Methods Both in vitro and in vivo assays were performed to investigate the roles of lncRNA in pathophysiology of AS. Our previous lncRNA arrays revealed that lncRNA RP4-639F20.1 were significantly decreased in atherosclerotic plaques. Lentivirus overexpressing RP4-639F20.1 and lncRNA RP4-639F20.1 silencing vectors (Si-lnc-RP4-639F20.1) were constructed and transfected in VSMCs. The in vitro functions of lncRNA were analyzed by CCK-8 assays, EdU assays, scratch wound assays, Transwell assays, qRT-PCR analyses and Western blot analyses. RNA fluorescence in situ hybridization, immunoprecipitation and mRNA microarrays were used to explore the underlying mechanism. Adeno-associated-virus-9 (AAV9) overexpressing RP4-639F20.1 were constructed and injected intravenously into ApoE−/− mice to explore the role of lncRNA in vivo. Results In vitro experiments showed that lncRNA RP4-639F20.1 interacted with THRAP3 and downregulated c-FOS expression. Both augmentation of lncRNA RP4-639F20.1 expression and knockdown c-FOS inhibited the expression of MMP10 and VEGF-α in VSMCs and suppressed VSMCs proliferation and migration. In vivo experiments usingApoE−/− mice fed a high-fat diet demonstrated that lncRNA RP4-639F20.1 overexpression deterred atherosclerosis and decreased lipid contents in atherosclerotic lesions. Patients with coronary artery disease were found to have higher c-FOS levels than healthy individuals and c-FOS expression was positively correlated with the SYNTAX score of patients. Conclusions Overall these data indicated that lncRNA RP4-639F20.1/THRAP3/c-FOS pathway protects against the development of atherosclerosis by suppressing VSMCs proliferation and migration. LncRNA RP4-639F20.1 and c-FOS could represent potential therapeutic targets to ameliorate atherosclerosis-related diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI